Table 2.
Associations between circ_BICD2 expression and clinicopathological characteristics
| Clinical feature | Number | Expression of circ_BICD2 | P value | |
|---|---|---|---|---|
|
| ||||
| aHigh | Low | |||
| 30 | 17 (56.67%) | 13 (43.33%) | ||
| Age (years) | 0.880 | |||
| ≥60 | 18 | 10 (33.34%) | 8 (26.66%) | |
| <60 | 12 | 7 (23.33%) | 5 (16.67%) | |
| Sex | 0.785 | |||
| Male | 17 | 10 (33.34%) | 7 (23.33%) | |
| Female | 13 | 7 (23.33%) | 6 (20.00%) | |
| Tumor size (cm) | 0.013 | |||
| ≥3 | 19 | 14 (46.66%) | 5 (16.67%) | |
| <3 | 11 | 3 (10.00%) | 8 (26.66%) | |
| TNM stage | 0.035 | |||
| I-II | 12 | 4 (13.34%) | 8 (26.66%) | |
| III-IV | 18 | 13 (43.33%) | 5 (16.67%) | |
| Lymph node metastasis | 0.004 | |||
| No | 12 | 3 (10.00%) | 9 (30.00%) | |
| Yes | 18 | 14 (46.66%) | 4 (13.34%) | |
a
The median of relative circ_BICD2 expression level is 4.3, so the number of high circ_BICD2 expression is 17 (>4.3).